21st SAHF Global Virtual Conference 2020

Virtual Diabetes and MultiMorbidity, Challenges and Education in a Global Pandemic

Thursday, 15th October 2020

(UK Time)
Session Presenter(s)
11:00 –11:10

Chair’s welcome (SAHF perspective)

Professor Kiran Patel
11:10 – 11:30

Diabetes “Language Matters”

Professor Partha Kar
11:30 – 11:50

Diabetes UK perspective

Mr Chris Askew
11:50 – 12:10

NHS diabetes perspective

Professor Jonathan Valabhji
12:10 – 12:30

Panel Discussion

Professor Jonathan Valabhji and Professor Partha Kar
12:30 – 12:50
Latest update on Trials
  • Gain an up to date understanding of key recent trials in diabetes and their outcomes, including updates on diabetes and COVID-19, SGLT2 inhibitors and from recent conferences.
Dr Amar Puttanna
12:50 –13:10
20 minute Break 
“Are GLP1RA the second line drug of choice for South Asians”?
Symposium Sponsored by Novo Nordisk
Dr Abd Tahrani  
13:45– 14:15

COVID 19: Ethnicity and Mental Health

  • What differences are there in mental health linked to ethnicity in the UK and why?

  • How has covid19 impacted differentially, linked to ethnicity?

  • What practical steps can we take to bridge the disparity of health and life outcomes of those from ethnic minorities?

Dr Sridevi Kalidindi

NASH/NAFLD in relation to T2DM

  • Burden of NASH and advanced fibrosis in patients with T2DM

  • New methods to identify patients with advanced fibrosis

  • New treatments being developed.

Professor Philip Newsome

Low carbohydrate diet versus low calorie diet

  • To understand key points on nutrition composition and health 
  • To understand facts and myths about low-carb and low-calorie diets 
  • To leave with greater knowledge & less confusion than before the session
Professor Nita Forouhi
15:15– 15:45

‘Novel Insights from recent CVOTS’

  • To understand the pathogenesis of DKD, including Asian origin as an important risk factor, and the implications of DKD for cardiometabolic risk.

  • To understand the recent data from the CREDENCE and Dapa-CKD trials.

  • To understand the relevance of DKD in the management guidelines for Diabetes Mellitus, and the role of the SGLT2-Inhibitor class to improve overall cardio-renal outcomes in patients with Diabetes Mellitus.

Dr Thomas Barber
15:45 – 16:10

25 minute Break

16:10 – 16:45

“Ethnicity and COVID 19”

Symposium Sponsored by Abbott
Professor Wasim Hanif
16:45 – 16:50 Introduction: Lifetime Achievement Award Professor Wasim Hanif and
Professor Kamlesh Khunti  
16:50 – 17:50

Lifetime Achievement Award 

‘Diabetes in South Asians: Harnessing Ancient and Modern Knowledge into Action’


  • What are the dominant cause of the diabetes excess in South Asians?
  • How has 'omics increased our understanding of causes?
  • How do we harness this vast knowledge of diabetes causes into effective prevention strategies?
Dr Sonia Anand, Canada
17:50 – 18:00

Closing statements

Professor Kamlesh Khunti and Professor Wasim Hanif